BCL9 and breast carcinoma: METABRIC database in cBioPortal, which includes 2,509 cases of breast cancer15,16, showed significantly higher BCL9 mRNA expression in luminal A, B and basal-like breast cancers compared to other subtypes (Supplementary Fig. 1a, b).